(Reuters) -Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a ...

At the outset of the war triggered by Hamas' October 2023 attack on Israel, the central bank told lenders to hold off on ...

Russia intends to launch a ballistic missile capable of carrying a nuclear warhead on Sunday to intimidate Ukraine and the ...